In an interview with broadcast media, US Health and Human Services Secretary Alex Azar said that his department was looking to augment the measures set out in the White House budget proposal, to further reduce drug prices.
“We look forward to working with Congress to get those proposals enacted and we're continuing to work with more proposals that we'll move forward with on our own authority if we're able,” he said.
President Donald Trump’s budget requests, which would include a 20% reduction to the budget of Mr Azar’s department, include taking a quarter of a billion dollars from Medicare by rolling back Obama-era expansions.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze